Web Analytics Made Easy - StatCounter

Isoxsuprine Tablet Tenders

Get complete information related to latest Isoxsuprine Tablet Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Isoxsuprine Tablet Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Isoxsuprine Tablet Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :44767553 Due date: 20 Apr, 202620 Apr, 2026 10.96 Lacs
Tender For corrigendum : supply of megesterol acetate 40mg tab , vinorelbine 50 mg inj , brivaracetum 50 mg tab , rivastigmine 9 dot 5mg 24 hrs transdermal patch 10 sq cm pack of 30 patches , pyridostigmine 60 mg tab , actinomycin d 0 dot 5 mg inj , fenofibrate 160 mg tab , cetrizine syp 5mg 5ml bott of 60 ml , brimonidine tartrate 0 dot 2 percent eye drops bott of 5 ml , brinzolamide 5ml eye drops , cyclopentolate hcl 1 percent opth soln bottle of 5 ml , dorzolamide 2 percent plus timolol 0 dot 5 percent eye drops , gatifloxacin 0 dot 3 percent eye drop bott of 5 ml , gatifloxacin 0 dot 3 percent plus dexamethasone 1 percent vial of 5ml eye drops , gatifloxacin plus prednisolone 5ml eye drops , gatifloxacin plus ketorolac 5 ml eye drops , homatropine hydrochloride soln 2 percent bottle of 5 ml , ketorolac tromethamine 0 dot 4 percent eye drop , moxifloxacin 0 dot 50 percent oint , povidone 5 percent eye drop bott of 5 ml , proparacaine 0 dot 5 percent 0 dot 74 percent 5ml eye drops , tobramycin 0 dot 3 percent bott of 5 ml , sodium chloride eye drops 5 percent 5 ml bott , moxifloxacin 0 dot 5 percent with dexamethasone phosphate 0 dot 1 percent 5ml eye drop , latanoprost 0 dot 005 percent plus 0 dot 2mg bakin 2 dot 5ml volume bott with dropper applicator e d , dorzolamide 2 percent eye drops , voriconazole eye drops , bromfenac 0 dot 09 percent eye drops , moxifloxacin 0 dot 5 percent with prednisolone 1 percent 5 ml eye drop , fluorometholone acetate 0 dot 1 percent 5ml eye drops , prednisolone acetate 1 percent w v bott of 5 ml , olopatadine 0 dot 1 percent 5ml eye drops , olopatadine 0 dot 2 percent eye drops , brimonidine 0 dot 2 percent plus timolol 0 dot 5 percent with preservative bak 0 dot 02 percent eye drops , nepafenac 0 dot 1 percent 5ml eye drop , e d olopatadine hydrochloride 0 dot 1 percent plus ketorolac tromethamine 0 dot 4 percent , brinzolamide 1 percent plus timolol maleate 0 dot 5 percent with droptainer dispensing system , netarsudil 0 dot 02 percent eye drop bottle of 3 ml , bimatoprost 0 dot 03 percent bott of 3ml , flurbiprofen sodium ophthalmic soln 0 dot 03 percent vial of 5 ml , eye drop brimonidine 0 dot 2 percent plus brinzolamide 1 percent bottle of 5 ml , tropicamide eye solution 1 percent bott of 5 ml , hydroxy propyl methyl cellulose 2 percent eye oint , timolol maleate eye drop 0 dot 5 percent bott of 5 ml , hyaluronidase 1500 iu inj , tropicamide 1 percent with 5 percent phenylephrine eye drops bott of 5 ml , inj mitomycin c 10 mg , albendazole 400 mg tab , tinidazole 500 mg tab , silver sulphadiazine 1 percent cream w v jar of 500 gms , amoxycillin 250 mg cap //bid details 2 / 43

State Government

CTN :44804752 Due date: 21 Apr, 202621 Apr, 2026 NA
Tender For quotation enquiry for "oncology medicines" under two envelope (two bid) system inj. aprepitant/fosaprepitant , inj. bleomycin (15 unit) , inj. bortezomib (2 mg) , in). bevacizumab (100 mg) , inj. bevacizumab (300 mg) , inj. bendamustine hci (100mg) , inj. cisplatin (50 mg) , inj. cyclophosphamide (1 gm) , inj. cytarabine [100mg) , inj, carboplatin (150 mg) , inj. carboplatin 450 mg) , inj. dacarbazine (100mg) , inj. dacarbazine (500mg) , inj. dactinomycin (0.5 mg) , inj. daratumumab 400mg (darzalex) , inj. denosumab (120 mg) , in). doxorubicin (50 mg) , inj. docetaxel (120 mg)-rtu , inj. docetaxel (120 mg) , in). docetaxel (80 mg)-rtu , inj. docetaxel (80 mg) , inj. nanosomal docetaxel lipid suspension (80mg) , inj. epirubicin (100 mg) , inj. etoposide 100 mg) , inj. filgrastim (300ug/0.5 ml) , inj. fulvestrant (250 mg) , inj. 5-fluorouracil (500 mg) , inj. gemcitabine (1gm) , inj. gemcitabine (200mg) , inj. gemcitabine (1.4 gm) , inj. gemcitabin (1.4 gm)-rtu , inj. granisetron 3mg/3ml) , in). irinotecan (100mg) , ing. uposoma , inj. l asparginase (5000 iu) , inj. leuprolide (22.5 mg) , inj. mesna (200mg) , inj. methotrexate (50 mg) , inj. mitomycin (10 mg) , inj. mitoxantrone (10mg) , inj. nivolumab (40mg) , in). nivolumab (100mg) , inj. ondansetron (8 mg) , inj. oxaliplatin (100 mg) , inj. oxaliplatin (150 mg vial) , in). paclitaxel/260 mg) , inj. paclitaxel (100 mg) , inj. nab paclitaxel (100mg) , inj. paclitaxel (300 mg) , inj. nanosomal paclitaxel lipid suspension (100mg) , inj. octreotide lar (20mg) , inj. pemetrexed (100 mg) , in). pemetrexed (500 mg) , inj. peg filgrastim (0.6mg) pfs , inj. peg-l-asparginase 750 iu/ml , inj. palonosetron (0.25 mg) , inj. pertuzumeb (420 mg) , in). rituximab (500 mg) , inj. rituximab (100 mg) , inj. romipiostim (225 ug) , inj. romiplostim (250 ug) , inj.serplullmab (100mg) , in). trastuzumab (440mg) , iv. aminoven 10%, 250 ml , iv. aminoven 10%, 500 ml , artificial saliva supplement spray (50 ml) , artificial saliva supplement spray (100 ml) , benzydamine mouthwash (500 ml) , betamethasone oral drop (15ml) , bioavailable nanocurcumin suspension (100 ml) , bioavailable nanocurcumin suspension (150 ml) , benzocaine gel (15 gm) , chiarhexidine mouthwash (100 ml) , curcumin lozenges , clotrimazole lozenges (10 mg) , l-glutamine (15 gm) sachet , lidocaine viscous (400ml) , lignocaine lozenges , melatonin oral spray (30 ml) , protein powder (200 gm) , framycetin skin cream 30 gm , radiation repair gel (100ml) , radiation repair lotion , total parentral nutrition (kabiven) , benzydamine oral spray , lidocaine spray 10% w/v , curcumin co-enzyme q10 , benzydamine chlorhexadine mouthwash

Central Government/Public Sector

CTN :44588482 Due date: 20 Apr, 202620 Apr, 2026 NA
Tender For corrigendum : supply of (ami 26-27) mitomycin 40mg inj.
 Loading, Please wait...

Connect us via What's Up